Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,197 | 6,171 | 1,962 | N/A | 0 |
| Receivables | 174 | 137 | 125 | N/A | 0 |
| TOTAL | $7,630 | $6,560 | $2,243 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 9 | 11 | 10 | N/A | N/A |
| Investments And Advances | 5,172 | 745 | 0 | 0 | 0 |
| TOTAL | $5,181 | $756 | $10 | $N/A | $N/A |
| Total Assets | $12,810 | $7,316 | $2,254 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 645 | 394 | 3,311 | 0 | 0 |
| Other current liabilities | 298 | 200 | 149 | N/A | 0 |
| TOTAL | $943 | $594 | $3,509 | $N/A | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $943 | $594 | $3,509 | $N/A | $0 |
| Shareholders' Equity | |||||
| Common Shares | 68,885 | 61,752 | 52,941 | N/A | 0 |
| Retained earnings | -58,440 | -56,447 | -54,498 | N/A | 0 |
| Other shareholders' equity | 1,422 | 1,417 | 303 | 0 | 0 |
| TOTAL | $11,867 | $6,722 | $-1,255 | $N/A | $0 |
| Total Liabilities And Equity | $12,810 | $7,316 | $2,254 | $0 | $0 |